Palatin to Deliver Plan of Compliance to NYSE American CRANBURY, N.J., Oct. 13, 2023 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor…